Form 4: CalciMedica CBO Eric Roberts Boosts Stake
Insider Transaction Report
CalciMedica's Chief Business Officer and Director, Eric W. Roberts, increased his beneficial ownership by purchasing 3,508 shares of common stock.
Summary
- Eric W. Roberts, who serves as a Director, 10% Owner, and Chief Business Officer of CalciMedica, Inc. (CALC), acquired additional shares.
- On August 21, 2025, Mr. Roberts purchased 3,508 shares of CalciMedica Common Stock.
- The shares were acquired at a weighted average price of $2.7928 per share, with prices ranging from $2.75 to $2.80.
- This transaction was made pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
- Following this transaction, Mr. Roberts' total beneficial ownership in CalciMedica, Inc. stands at 1,040,494 shares of Common Stock, held directly and indirectly through various entities.
Sentiment
Score: 7
Explanation: The insider purchase by a key executive is a positive signal of management confidence, although the transaction size is relatively modest compared to total beneficial ownership.
Positives
- A key executive, Eric W. Roberts, increased his stake in the company, signaling confidence in CalciMedica's future prospects.
- The purchase was made under a Rule 10b5-1 plan, indicating a pre-planned commitment to invest in the company's equity.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders may view this insider purchase as a positive indicator of management's belief in the company's value and future prospects, potentially boosting investor confidence.
Key Dates
| Date | Description |
|---|---|
| 08/21/2025 | Date of transaction where Eric W. Roberts acquired 3,508 shares of Common Stock. |
| 08/25/2025 | Date the Statement of Changes in Beneficial Ownership (Form 4) was signed and filed. |
Recommendation
holdThe purchase by a key executive, Eric W. Roberts, signals management's confidence in CalciMedica's prospects. While the transaction size is not exceptionally large, it provides a positive indicator for existing shareholders and suggests a 'hold' position is warranted, as it counters potential negative sentiment and aligns management's interests with shareholders.
Keywords
CalciMedica, CALC, Eric Roberts, insider trading, Form 4, stock purchase, beneficial ownership, Chief Business Officer, Director, 10b5-1 plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.